Clinical outcomes and prognostic factors in patients with newly diagnosed metastatic prostate cancer initially treated with androgen deprivation therapy: a retrospective multicenter study in Japan.
Shintaro NaritaShingo HatakeyamaMasahiro TakahashiToshihiko SakuraiSadafumi KawamuraSenji HoshiMasanori IshidaToshiaki KawaguchiShigeto IshidoyaJiro ShimodaHiromi SatoAtsushi KoizumiKoji MitsuzukaTatsuo TochigiNorihiko TsuchiyaChikara OhyamaYoichi AraiKyoko NomuraTomonori HabuchiPublished in: International journal of clinical oncology (2020)
In this series, CRPC-free and OS of a subset of mHNPC patients in Japan who were treated with ADT or CAB had better CRPC-free and overall survivals in Japan. Risk-adapted treatment based on the presence of novel prognostic factors may be beneficial for selected mHNPC patients.